Tempest Therapeutics Extends Limited Duration Stockholder Rights Plan; Shares Rise Premarket

MT Newswires Live10-10

Tempest Therapeutics (TPST) said Thursday that its board approved an amendment to extend the company's limited duration stockholder rights plan until the annual shareholder meeting.

The company's trading price continues to "fundamentally undervalue" Tempest Therapeutics and the stockholder rights plan is put in place to help shareholders realize the long-term value of their stakes, said Tempest Chief Executive Officer Stephen Brady.

Tempest Therapeutics said the extension is not a response to a specific takeover threat and does not prevent its board from accepting acquisition proposals or engaging with interested parties.

Shares of the company rose more than 34% in recent premarket activity.

Price: 1.81, Change: +0.46, Percent Change: +34.07

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2474592711?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-10-10 19:37","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2474592711","market":"hk","top_or_hot":-1,"title":"Tempest Therapeutics Extends Limited Duration Stockholder Rights Plan; Shares Rise Premarket","media":"MT Newswires Live","content":"<html><body><p> Tempest <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> (TPST) said Thursday that its board approved an amendment to extend the company's limited duration stockholder rights plan until the annual shareholder meeting.</p><p>The company's trading price continues to \"fundamentally undervalue\" Tempest Therapeutics and the stockholder rights plan is put in place to help shareholders realize the long-term value of their stakes, said Tempest Chief Executive Officer Stephen Brady.</p><p>Tempest Therapeutics said the extension is not a response to a specific takeover threat and does not prevent its board from accepting acquisition proposals or engaging with interested parties.</p><p>Shares of the company rose more than 34% in recent premarket activity.</p><p>Price: 1.81, Change: +0.46, Percent Change: +34.07</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tempest Therapeutics Extends Limited Duration Stockholder Rights Plan; Shares Rise Premarket</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTempest Therapeutics Extends Limited Duration Stockholder Rights Plan; Shares Rise Premarket\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-10-10 19:37 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.mtnewswires.com/><strong>MT Newswires Live</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Tempest Therapeutics (TPST) said Thursday that its board approved an amendment to extend the company's limited duration stockholder rights plan until the annual shareholder meeting.The company's ...</p>\n\n<a href=\"https://www.mtnewswires.com/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LENZ","symbol_name":"Therapeutics","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2474592711","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2474592711","pubTimestamp":1728560252,"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Tempest Therapeutics  said Thursday that its board approved an amendment to extend the company's limited duration stockholder rights plan until the annual shareholder meeting.The company's trading price continues to \"fundamentally undervalue\" Tempest Therapeutics and the stockholder rights plan is put in place to help shareholders realize the long-term value of their stakes, said Tempest Chief Executive Officer Stephen Brady.Tempest Therapeutics said the extension is not a response to a specific takeover threat and does not prevent its board from accepting acquisition proposals or engaging with interested parties.Shares of the company rose more than 34% in recent premarket activity.Price: 1.81, Change: +0.46, Percent Change: +34.07","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"LENZ":"Therapeutics","BK4139":"生物科技","TPST":"Tempest Therapeutics Inc."},"translate_title":"Tempest Therapeutics延长有限期限股东权利计划；股价盘前上涨","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"LENZ":1,"TPST":0.9},"content_text":"Tempest Therapeutics (TPST) said Thursday that its board approved an amendment to extend the company's limited duration stockholder rights plan until the annual shareholder meeting.The company's trading price continues to \"fundamentally undervalue\" Tempest Therapeutics and the stockholder rights plan is put in place to help shareholders realize the long-term value of their stakes, said Tempest Chief Executive Officer Stephen Brady.Tempest Therapeutics said the extension is not a response to a specific takeover threat and does not prevent its board from accepting acquisition proposals or engaging with interested parties.Shares of the company rose more than 34% in recent premarket activity.Price: 1.81, Change: +0.46, Percent Change: +34.07","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2474592711"}